My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
January 2014
Top Story
From the President: New Website Provides Clinicians with Timely Advice on HCV

HCVguidelines.org, a new website developed by IDSA and the American Association for the Study of Liver Disease (AASLD) in collaboration with the International Antiviral Society-USA (IAS-USA), offers evidence-based, consensus recommendations for the screening, treatment and management of patients with HCV.

ADAPT Act Would Promote New Drug Development

New bipartisan legislation supported by IDSA would advance drug development by establishing a new limited population antibacterial and antifungal drug approval pathway for drugs to treat serious or life-threatening infections where there exists an unmet medical need.

Updated Guideline for Vaccination of Immunocompromised Host Now Available

IDSA’s updated guideline was developed in an effort to make it easier for clinicians to rapidly find vaccine recommendations for the immunocompromised patient population.

IDSA Journal Club
This month’s studies investigating: Predicting Drug-Resistant Organisms in HCAP: Do We Always Need to Go Big?; Preventing Hepatic Decompensation in HIV-HCV Coinfected Individuals; Another Flu Shot Benefit: Meta-Analysis Suggests Reduction in Cardiovascular Events After Vaccination; Eradication of CRE Gastrointestinal Colonization with Oral Antibiotics; Is Amoxicillin Really Associated with Rash in Acute EBV Infection?
Upcoming dates to remember 

 

  • The combined meeting of IDSA, SHEA, HIVMA, and PIDS, Oct. 8-12, 2014, in San Francisco. Stay tuned for more information at www.idweek.org.

Renew Your IDSA Membership!
Due now!

Medical Scholars Program Deadline
Feb. 3, 2014

6th Annual IDSA Fellows In-Training Exam
Feb. 4-5, 2014

Joint Research Awards Application Deadline
Mar. 17, 2014

Society Awards Nomination Deadline
Apr. 1, 2014

HIVMA Leadership Awards Nomination Deadline
Apr. 15, 2014

Patient Care and Science
FDA Approves Simeprevir and Sofosbuvir for Chronic Hepatitis C
Policy and Advocacy
Congress Approves Partial Relief from Sequestration Funding Cuts
IDSA Supports Diagnostics Bill Moving through House of Representatives
IDSA and PIDS Submit Comments to FDA on Proposed Drug Shortage Rule
Congressional Briefing Highlights Barriers to Immunization for Older Adults
IDSA, SHEA, PIDS Call for Mandatory Immunization of Health Care Personnel
HIVMA Welcomes HIV Policy Assessment Directive in Defense Bill
President Obama Mentions Vaccines and Drug Resistance in State of the Union
Clinical Practice Management
New Resource Helps ID Specialists Prove Their Value
President Obama Signs Bill to Prevent Scheduled Medicare Cut
Science Speaks Blog
The Center for Global Health Policy Examines the Impact of Drug Prices on Vulnerable Populations, and Other Newsworthy Events
You and Your Colleagues
Renew Dues and Update Your Membership
Members on the Move
New Members
In Memoriam: Martin C. McHenry, MD, MS, FIDSA (1932-2013)
Education and Resources
Free Online Course on Antimicrobial Stewardship
Changes to ABIM MOC Now In Effect
Open Forum Infectious Diseases Now Accepting Submissions
Apply Now for the ID Research Careers Meeting
Top Story
From the President: New Website Provides Clinicians with Timely Advice on HCV
ADAPT Act Would Promote New Drug Development
Updated Guideline for Vaccination of Immunocompromised Host Now Available
IDSA Journal Club

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.

Unsubscribe here